Literature DB >> 17667806

A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation.

Jeffrey J Gaynor1, Jang I Moon, Tomoaki Kato, Seigo Nishida, Gennaro Selvaggi, David M Levi, Eddie R Island, Nikolaos Pyrsopoulos, Debbie Weppler, Susan Ganz, Phillip Ruiz, Andreas G Tzakis.   

Abstract

BACKGROUND: In orthotopic liver transplantation (OLT) distinct causes of graft failure (GF) and death with a functioning graft (DFG) exist. Prognostic factors for one failure type may be distinctly different from those predictive of other types, and an accurate portrayal of these relationships may more clearly explain each factor's importance.
METHODS: A multivariable cause-specific hazard (CSH) rate analysis using Cox stepwise regression was performed among 877 adults who received primary OLT during 1996-2004 with tacrolimus+steroids as immunosuppression.
RESULTS: Older donor age (P=0.004) implied greater primary dysfunction GF, while primary sclerosing cholangitis (PSC; P=0.0002) implied greater vascular thrombosis GF. Recurrent nonmalignant liver disease GF was higher among hepatitis C virus patients (P<0.00001), and younger recipient age (P=0.005) implied greater death from recurrent (metastatic) hepatocellular carcinoma. African-American race (P<0.00001), PSC (P=0.003), and younger recipient age (P=0.005) were independently associated with greater GF due to chronic rejection. Older donor age (P=0.003) implied greater infection DFG, while older recipient age (P=0.003) and pretransplant diabetes (P=0.03) were independently associated with greater cardiovascular/cerebrovascular DFG. Finally, most of these cause-specific predictors were not significant in an overall Cox model for graft survival.
CONCLUSIONS: The CSH approach should be more widely used in investigations of prognostic factors. The result of older donor age implying greater primary dysfunction GF and infection DFG but having no association with other failure types demonstrates that its impact is specific to the graft's early posttransplant functional status. In addition, while recipient age was an important prognosticator, its direction of association reverses depending upon the outcome being analyzed.

Entities:  

Mesh:

Year:  2007        PMID: 17667806     DOI: 10.1097/01.tp.0000269090.90068.0f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Neurologic complications after liver transplantation.

Authors:  Saša A Zivković
Journal:  World J Hepatol       Date:  2013-08-27

2.  Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report.

Authors:  T Hranjec; H Bonatti; A L Roman; C Sifri; S M Borowitz; B H Barnes; T R Flohr; T L Pruett; R G Sawyer; T M Schmitt
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

3.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

Review 4.  Liver transplantation in the ethnic minority population: challenges and prospects.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

5.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

6.  Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients.

Authors:  Zhiyong Guo; Xiaoshun He; Linwei Wu; Weiqiang Ju; Anbin Hu; Qiang Tai; Dongping Wang; Yi Ma; Guodong Wang; Xiaofeng Zhu; Jiefu Huang
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

Review 7.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.